Clinical Utility of the OmniGraf Biomarker Panel in the Care of Kidney Transplant Recipients (CLARITY): Protocol for a Prospective, Multisite Observational Study.

Fleming, James N; Cober, Timothy; Hickey, Janelle; Stach, Leslie; Kawano, Allison; Szczepanik, Amanda; Watson, Alicia; Imamura, Yuka; Weems, Juston; West-Thielke, Patricia

Fleming, James N; Cober, Timothy; Hickey, Janelle; Stach, Leslie; Kawano, Allison; Szczepanik, Amanda; Watson, Alicia; Imamura, Yuka; Weems, Juston; West-Thielke, Patricia.

Afiliação

Fleming JN; Transplant Genomics, Inc, Framingham, MA, United States.
Cober T; Transplant Genomics, Inc, Framingham, MA, United States.
Hickey J; Transplant Genomics, Inc, Framingham, MA, United States.
Stach L; Transplant Genomics, Inc, Framingham, MA, United States.
Kawano A; Transplant Genomics, Inc, Framingham, MA, United States.
Szczepanik A; Transplant Genomics, Inc, Framingham, MA, United States.
Watson A; Transplant Genomics, Inc, Framingham, MA, United States.
Imamura Y; Transplant Genomics, Inc, Framingham, MA, United States.
Weems J; Transplant Genomics, Inc, Framingham, MA, United States.
West-Thielke P; Transplant Genomics, Inc, Framingham, MA, United States.

JMIR Res Protoc ; 11(12): e41020, 2022 Dec 14.

Article em En | MEDLINE | ID: mdl-36515980

Palavras-chave

adverse drug event; adverse event; allograft; biomarker; chronic condition; clinical trial; eGFR; kidney; kidney transplant; medication management; medication monitoring; nephrology; observational study; patient outcome; quality of life; renal; renal function; transplant

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google